A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis

Arthroscopy - Journal of Arthroscopic and Related Surgery

Volumn 28, Issue 8, 2012, Pages 1070-1078

  Sánchez, Mikel ^a   Fiz, Nicolás ^a   Azofra, Juan ^a   Usabiaga, Jaime ^b   Aduriz Recalde, Enmanuel ^b   Garcia Gutierrez, Antonio ^b   Albillos, Javier ^c   Gárate, Ramón ^c   Aguirre, Jose Javier ^d   Padilla, Sabino ^d   Orive, Gorka ^d   Anitua, Eduardo ^d  

^a Unidad Cirugía Artroscópica USP Clínica la Esperanza   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

^c Policlínica Guipuzcoa   (Spain)

^d Biotechnology Institute BTI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; RECOMBINANT GROWTH FACTOR;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; JOINT STIFFNESS; KNEE OSTEOARTHRITIS; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY;

ARTHRALGIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PLASMA; TIME FACTORS;

EID: 84864419660     PISSN: 07498063     EISSN: 15263231     Source Type: Journal    
DOI: 10.1016/j.arthro.2012.05.011     Document Type: Article

References (30)

1. A.A. Guccione, D.T. Felson, J.J. Anderson The effects of specific medical conditions on the functional limitations of elders in the Framingham Study Am J Public Health 84 1994 351 358 (Pubitemid 24107816)
2. J.W.J. Bijlsma, F. Berenbaum, F.P.J.G. Lafeber Osteoarthritis: An update with relevance for clinical practice Lancet 377 2011 2115 2126
3. Centers for Disease Control and Prevention (CDC) Prevalence of disabilities and associated health conditions among adults - United States, 1999 MMWR Morb Mortal Wkly Rep 50 2001 120 125
4. S.P. Johnsen, H. Larsson, R.E. Tarone Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: A population-based case-control study Arch Intern Med 165 2005 978 984 (Pubitemid 40638117)
5. W. Zhang, R.W. Moskowitz, G. Nuki OARSI recommendations for the management of hip and knee osteoarthritis, part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence Osteoarthritis Cartilage 15 2007 981 1000 (Pubitemid 47393443)
6. J. Karlsson, L.S. Sjogren, L.S. Lohmander Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis: A controlled, randomized, double-blind, parallel-design multicenter study Rheumatology (Oxford) 41 2002 1240 1248 (Pubitemid 35363798)
7. J. Arrich, F. Piribauer, P. Mad Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: Systematic review and meta-analysis CMAJ 172 2005 1239 1242
8. F. Navarro-Sarabia, P. Coronel, E. Collantes A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: The AMELIA project Ann Rheum Dis 70 2011 1957 1962
9. R.R. Bannuru, N.S. Natov, U.R. Dasi, C.H. Schmid, T.E. McAlindon Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis - Meta-analysis Osteoarthritis Cartilage 19 2011 611 619
10. T. Spaková, J. Rosocha, M. Lacko Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid Am J Phys Med Rehabil 91 2012 411 417
11. M.B. Goldring, K.B. Marcu Cartilage homeostasis in health and rheumatic diseases Arthritis Res Ther 11 2009 224
12. E.V. Tchetina, J. Antoniou, M. Tanzer, D.J. Zukor, A.R. Poole Transforming growth factor-beta2 suppresses collagen cleavage in cultured human osteoarthritic cartilage, reduces expression of genes associated with chondrocyte hypertrophy and degradation, and increases prostaglandin E(2) production Am J Pathol 168 2006 131 140 (Pubitemid 43062566)
13. M.B. Schmidt, E.H. Chen, S.E. Lynch A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair Osteoarthritis Cartilage 14 2006 403 412
14. J.P. Pujol, C. Chadjichristos, F. Legendre Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism Connect Tissue Res 49 2008 293 297
15. E. Kon, B. Mandelbaum, R. Buda Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis Arthroscopy 27 2011 1490 1501
16. G. Filardo, E. Kon, M.T. Pereira Ruiz Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach Knee Surg Sports Traumatol Arthrosc 2011 Dec 28 [Epub ahead of print.]
17. E. Anitua, M. Sánchez, G. Orive Potential of endogenous regenerative technology for in situ regenerative medicine Adv Drug Deliv Rev 62 2010 741 752
18. E. Anitua, M. Sánchez, A.T. Nurden Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients Rheumatology (Oxford) 46 2007 1769 1772 (Pubitemid 350168290)
19. E. Anitua, M. Sánchez, M.M. Zalduendo Fibroblastic response to treatment with different preparations rich in growth factors Cell Prolif 42 2009 162 170
20. J. Zhang, J.H. Wang Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes Am J Sports Med 38 2010 2477 2486
21. P. Bendinelli, E. Matteucci, G. Dogliotti Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-κB inhibition via HGF J Cell Physiol 225 2010 757 766
22. M. Sánchez, E. Anitua, J. Azofra, J.J. Aguirre, I. Andia Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: A retrospective cohort study Clin Exp Rheumatol 26 2008 910 913
23. R. Altman, E. Asch, D. Bloch Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee Arthritis Rheum 29 1986 1039 1049
24. M.C. Rowbotham What is a "clinically meaningful" reduction in pain? Pain 94 2001 131 132 (Pubitemid 33016605)
25. F. Salaffi, A. Stancati, C.A. Silvestri, A. Ciapetti, W. Grassi Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale Eur J Pain 8 2004 283 291 (Pubitemid 38859657)
26. T. Pham, D. van der Heijde, R.D. Altman OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited Osteoarthritis Cartilage 12 2004 389 399 (Pubitemid 38594267)
27. G.M. van Buul, W.L. Koevoet, N. Kops Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes Am J Sports Med 39 2011 2362 2370
28. J. Woodell-May, A. Matuska, M. Oyster, Z. Welch, K. O'Shaughnessey, J. Hoeppner Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes J Orthop Res 29 2011 1320 1326
29. A. Wang-Saegusa, R. Cugat, O. Ares, R. Seijas, X. Cuscó, M. García-Balletbó Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life Arch Orthop Trauma Surg 131 2011 311 317
30. G. Filardo, E. Kon, R. Buda Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis Knee Surg Sports Traumatol Arthrosc 19 2011 528 535